Skip Nav Destination
Close Modal
Update search
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
NARROW
Format
Article Type
Date
Availability
1-6 of 6
Keywords: adriamycin
Close
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Sort by
Articles
António Ascensão, José Lumini-Oliveira, Nuno G. Machado, Rita M. Ferreira, Inês O. Gonçalves, Ana C. Moreira, Franklin Marques, Vilma A. Sardão, Paulo J. Oliveira, José Magalhães
Journal:
Clinical Science
Clin Sci (Lond) (2011) 120 (1): 37–49.
Published: 17 September 2010
... against cardiac mitochondrial dysfunction, preserving mitochondrial phosphorylation capacity and attenuating DOX-induced decreased tolerance to MPTP opening. adriamycin apoptosis doxorubicin (DOX) exercise mitochondrial bioenergetics mitochondrial permeability transition pore (MPTP) DOX...
Articles
Gian Marco Ghiggeri, Fabrizio Ginevri, Giovanni Cercignani, Roberta Oleggini, Alessando Garberi, Giovanni Candiano, Paola Altieri, Rosanna Gusmano
Journal:
Clinical Science
Clin Sci (Lond) (1990) 79 (6): 647–656.
Published: 01 December 1990
...Gian Marco Ghiggeri; Fabrizio Ginevri; Giovanni Cercignani; Roberta Oleggini; Alessando Garberi; Giovanni Candiano; Paola Altieri; Rosanna Gusmano 1. A low protein diet prevents the development of proteinuria and glomerular damage in adriamycin experimental nephrosis without affecting renal...
Articles
Fabrizio Ginevri, Rosanna Gusmano, Roberta Oleggini, Silvia Acerbo, Roberta Bertelli, Francesco Perfumo, Giovanni Cercignani, Simone Allegrini, Franco D'Allegri, Gianmarco Ghiggeri
Journal:
Clinical Science
Clin Sci (Lond) (1990) 78 (3): 283–293.
Published: 01 March 1990
... in puromycin aminonucleoside and adriamycin experimental nephrosis by generating uric acid from hypoxanthine and xanthine. 2. The concentrations in renal tissue of the putative intermediary products of puromycin aminonucleoside metabolism, hypoxanthine and xanthine, and of their precursors, adenosine...
Articles
Akira Ohishi, Hiromichi Suzuki, Hidetomo Nakamoto, Hiroshige Katsumata, Hiroshi Sakaguchi, Takao Saruta
Journal:
Clinical Science
Clin Sci (Lond) (1989) 76 (4): 353–356.
Published: 01 April 1989
.... For this purpose, we studied the effects of captopril (a thiol-containing angiotensin converting enzyme inhibitor), enalapril (an angiotensin converting enzyme inhibitor without a thiol group) and cysteine (a thiol-containing amino acid which has no angiotensin converting enzyme-inhibitory action) in adriamycin...
Articles
Seiya Okuda, Kenichi Motomura, Tohru Sanai, Hideki Hirakata, Fumio Nanishi, Kaotu Onoyama, Masatoshi Fujishima
Journal:
Clinical Science
Clin Sci (Lond) (1987) 73 (1): 33–39.
Published: 01 July 1987
...Seiya Okuda; Kenichi Motomura; Tohru Sanai; Hideki Hirakata; Fumio Nanishi; Kaotu Onoyama; Masatoshi Fujishima 1. We examined the effects of various levels of dietary protein on the course of adriamycin-induced nephropathy in rats fed with high (30%), intermediately low (10%) or strictly low (5...
Articles
Journal:
Clinical Science
Clin Sci (Lond) (1986) 71 (1): 23–29.
Published: 01 July 1986
... of adriamycin (ADR). Serial changes of urinary protein, blood pressure and blood chemistry for 22 weeks after ADR-treatment, and renal histology at week 22, were compared between ADR-treated SHR (group ADR-HT) and ADR-treated SHR given antihypertensive drugs (group ADR-AH). 2. Hypertension persisted in group...